Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1968 1
1969 2
1970 4
1971 1
1973 1
1975 2
1976 3
1977 1
1978 2
1981 2
1982 1
1984 2
1985 2
1999 2
2000 1
2001 1
2002 1
2003 1
2004 5
2005 2
2006 1
2007 3
2008 3
2009 2
2010 1
2011 2
2018 4
2019 3
2020 1
2021 5
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
Locke FL, Miklos DB, Jacobson CA, Perales MA, Kersten MJ, Oluwole OO, Ghobadi A, Rapoport AP, McGuirk J, Pagel JM, Muñoz J, Farooq U, van Meerten T, Reagan PM, Sureda A, Flinn IW, Vandenberghe P, Song KW, Dickinson M, Minnema MC, Riedell PA, Leslie LA, Chaganti S, Yang Y, Filosto S, Shah J, Schupp M, To C, Cheng P, Gordon LI, Westin JR; All ZUMA-7 Investigators and Contributing Kite Members. Locke FL, et al. N Engl J Med. 2022 Feb 17;386(7):640-654. doi: 10.1056/NEJMoa2116133. Epub 2021 Dec 11. N Engl J Med. 2022. PMID: 34891224 Clinical Trial.
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
Westin JR, Oluwole OO, Kersten MJ, Miklos DB, Perales MA, Ghobadi A, Rapoport AP, Sureda A, Jacobson CA, Farooq U, van Meerten T, Ulrickson M, Elsawy M, Leslie LA, Chaganti S, Dickinson M, Dorritie K, Reagan PM, McGuirk J, Song KW, Riedell PA, Minnema MC, Yang Y, Vardhanabhuti S, Filosto S, Cheng P, Shahani SA, Schupp M, To C, Locke FL; ZUMA-7 Investigators; Kite Members. Westin JR, et al. N Engl J Med. 2023 Jul 13;389(2):148-157. doi: 10.1056/NEJMoa2301665. Epub 2023 Jun 5. N Engl J Med. 2023. PMID: 37272527 Clinical Trial.
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
Elsawy M, Chavez JC, Avivi I, Larouche JF, Wannesson L, Cwynarski K, Osman K, Davison K, Rudzki JD, Dahiya S, Dorritie K, Jaglowski S, Radford J, Morschhauser F, Cunningham D, Martin Garcia-Sancho A, Tzachanis D, Ulrickson ML, Karmali R, Kekre N, Thieblemont C, Enblad G, Dreger P, Malladi R, Joshi N, Wang WJ, Solem CT, Snider JT, Cheng P, To C, Kersten MJ. Elsawy M, et al. Among authors: rudzki jd. Blood. 2022 Nov 24;140(21):2248-2260. doi: 10.1182/blood.2022015478. Blood. 2022. PMID: 35839452 Free PMC article. Clinical Trial.
ASCO 2018 NSCLC highlights-combination therapy is key.
Gamerith G, Kocher F, Rudzki J, Pircher A. Gamerith G, et al. Among authors: rudzki j. Memo. 2018;11(4):266-271. doi: 10.1007/s12254-018-0444-7. Epub 2018 Oct 22. Memo. 2018. PMID: 30595752 Free PMC article. Review.
Partial-thickness rotator cuff tears.
Matava MJ, Purcell DB, Rudzki JR. Matava MJ, et al. Among authors: rudzki jr. Am J Sports Med. 2005 Sep;33(9):1405-17. doi: 10.1177/0363546505280213. Am J Sports Med. 2005. PMID: 16127127 Review.
Current treatment concepts of Philadelphia-negative MPN.
Wolf D, Rudzki J, Gastl G. Wolf D, et al. Among authors: rudzki j. Curr Cancer Drug Targets. 2011 Jan;11(1):44-55. doi: 10.2174/156800911793743592. Curr Cancer Drug Targets. 2011. PMID: 21062242 Review.
Internal impingement of the shoulder in the overhead athlete.
Drakos MC, Rudzki JR, Allen AA, Potter HG, Altchek DW. Drakos MC, et al. Among authors: rudzki jr. J Bone Joint Surg Am. 2009 Nov;91(11):2719-28. doi: 10.2106/JBJS.I.00409. J Bone Joint Surg Am. 2009. PMID: 19884449 Review.
67 results